ASSOCIATION OF CLINICAL AND BIOCHEMICAL FACTORS WITH SERUM TESTOSTERONE LEVELS IN TYPE 2 DIABETIC MALES Ravi Kumar Meena, Debasish Chaudhury, Amita.

Slides:



Advertisements
Similar presentations
High-density lipoprotein subclasses in subjects with impaired fasting glucose Filippatos TD 1, Barkas F 1, Klouras E 1, Liontos A 1, Rizos EC 1, Gazi I.
Advertisements

A comparison of overall health between Asian and Australians from European background: A west Australian study of Diet & Metabolic Syndrome Risk Factors.
Predictors of elevated transaminase levels in patients with central obesity V. Papastergiou, G. Ntetskas, L. Skorda, F. Lambrianou, K. Roufas, E. Asonitis,
Association of 1,5-Anhydroglucitol with Diabetes and Microvascular
The Prevalence of Male Hypotestosteronism in Type 2 Diabetics in a Southwest Virginia Population Dr. Eric Hofmeister Dr. Christopher Bishop.
1FHI 360 Nigeria. 2USAID Nigeria
Does the weight history of patients with newly diagnosed type 2 diabetes influence the weight changes after diabetes diagnosis? Niels de Fine Olivarius.
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Presented by Dr. Soe Sandi Tint
BASIC analysis of --- Stress/overwork and cardiovascular disease data Sino-Japanese cooperation project by Mile Xiu.
Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 15/10/58 1.
PREVELANCE OF COMPLICATIONS OF DIABETES MELLITUS IN EGYPT Prof Morsi Arab University of Alexandria.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients Dr. Mya Thandar.
Farid Saad Euro Weight Loss-2015 Frankfurt, Germany August 18 – 20, 2015.
High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
Risk factor profile for chronic non-communicable diseases: Results of a community-based study in Kerala, India K.R. Thankappan, Bela Shah*, Prashant Mathur*,
Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.
Mrs. Watcharasa Pitug ID The Association between Waist-to-Hight ratio, waist circumference,and Body Mass Index as Risk Factors for Chronic.
Dr Pulin Kumar Gupta Associate Professor Department of Medicine Incharge HIV/ART Centre PGIMER, Dr RML Hospital NEW DELHI INDIA.
EVALUATION OF CHARACTERS AND WBC DIFFERENCES BETWEEN DIABETES - COMPLICATIONS AMONG WORKERS OF FIRE AND MATCH FACTORIES IN SIVAKASI AREA STUDY CONDUCTED.
Marwan Ahmed Dr George Muntingh Prof Paul Rheeder
Title: Nutritional status of North Indian obese young adults Meenakshi Garg University of Delhi, India.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Fifth year medical student Phramongkutklao College of Medicine The Study of Prevalence and associated factors of Diabetic retinopathy in the Diabetic patients.
BLOOD LIPID DISORDER IN MEN WITH INCREASED WAIST CIRCUMFERENCE COMPARED TO MEN HAVING NORMAL WAIST CIRCUMFERENCE WITHIN THE SAME CATEGORY OF BMI. Organized.
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
METHODS INTRODUCTION I Webster, C Westcott, C Marincowitz, N Mashele, P De Boever, N Goswami, H Strijdom Division of Medical Physiology, Faculty of Medicine.
PREVALENCE AND RISK FACTORS FOR NON- ALCOHOLIC FATTY LIVER DISEASE AMONG AN URBAN AGING ADULT SRI LANKAN POPULATION– RAGAMA HEALTH STUDY 7-YEAR FOLLOW.
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli,
Regression coefficient (b) RESULTS AND DISCUSSION
Noncommunicable Diseases Surveillance in Egypt
Assoc.Prof.Dr. U. Tugba Simsek Gursoy, Istanbul University
The Plasma Concentrations of Atorvastatin and its Active Metabolites in Relation to the Dose in Stable Coronary Artery Disease Patients at a Tertiary Referral.
Visfatin in Type 2 Diabetes Mellitus
GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.
Safety and efficacy of insulin guideline for controlling perioperative hyperglycemia Marwa Amer PharmD Candidate1, Mark Shelly MD2, Dianne Lee PharmD Candidate1,
Non-metabolic syndrome mean (DS) Metabolic syndrome mean (DS)
Dietary patterns in a group of medical students
*Imperial College London
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
“The Bulgarians stand at the basis of human civilization
Dr. Syed Waleem Pasha Assistant Professor Yenepoya Medical College
Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,
Associations between Depression and Obesity: Findings from the National Health and Nutrition Examination Survey, Arlene Keddie, Ph.D. Assistant.
When Military Fitness Standards No Longer Apply
Prevalence Of Metabolic Syndrome And Assessment Of Nutritional And Biochemical Parameters Of Overweight And Obese Working Women 1Upasana, 2Chakravarty.
Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study M. Lazo, Y. Chen, J.W. McEvoy, C. Ndumele, S. Konety,
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
Mrs. Watcharasa Pitug ID
CURRENT TREND OF DIABETIC FOOT SURGERY IN GENERAL HOSPITAL OF KSA: ARE WE DOING ENOUGH TO AVOID AMPUTATIONS? Dr. Anthony Morgan, Dr. Adel Mohammad bin.
Dr Sunil Kumar Nanda, Bharathy N, Dr Lopamudra Ray
Insulin resistance in prepubertal children
Introduction Materials and Methods Results Conclusions
Frailty and its association with conventional risk factors for CAD among elderly patients with acute coronary syndrome.
Presenter : For : Dr. Dhananjay Gupta API-DSC 2016
Ahsan Kazmi, Khalid Mehmood Tariq, Rizwan Hashim
Jagadesh M ,SURYA NARAYANA J, JAYAPRAKASH, NRRAU
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Development of Steroid induced dysglycemia during the 48 hours of steroid therapy in hospitalized patients; its correlation with the type of steroid.
Comparison of lipid profile and glycosylated hemoglobin levels among HIV-infected and non-HIV-infected individuals in Lesotho: a community-based cross-sectional.
Baseline characteristics of HPS participants by prior diabetes
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Diabetes.
Latent TB Infection among Diabetic patients
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
The complications of obesity according to the values of BMI and waist circumference in an obese population of Tangier Nadia HAMJANE 1, Fatiha BENYAHYA1,2,
Presentation transcript:

ASSOCIATION OF CLINICAL AND BIOCHEMICAL FACTORS WITH SERUM TESTOSTERONE LEVELS IN TYPE 2 DIABETIC MALES Ravi Kumar Meena, Debasish Chaudhury, Amita Yadav Dept. of Medicine, Lady Hardinge Medical College, New Delhi

INTRODUCTION Low Serum Testosterone (LST) in diabetics is associated with: Reduced insulin sensitivity Visceral obesity Dyslipidaemia Cardiovascular burden There is absence of study on Indian population.

AIMS & OBJECTIVES To determine the association of serum testosterone level in type 2 male diabetics & healthy controls. To find out influence of various factors like Glycaemic status, Microvascular Complications, Obesity, waist circumference, and BMI on testosterone level.

MATERIALS AND METHODS STUDY DESIGN: Cross sectional observational study. STUDY PERIOD: November 2014 to March 2016. STUDY POPULATION: Patients of type 2 diabetes mellitus presenting to medical OPD of LHMC and Associated Hospitals & apparently healthy non diabetics. SAMPLE SIZE: 80 diabetic patients (cases) & 80 non diabetic apparently healthy age matched volunteers (controls) recruited for study. SAMPLING METHOD: Every alternate diabetic patient was screened for selection criteria and then recruited for study. Study was conducted after EC approval and informed written consent was obtained.

CRITERIA FOR SELECTION INCLUSION CRITERIA: Type 2 Diabetes with duration of diabetes ≥5 years Age ≥ 35 and ≤ 65 years   EXCLUSION CRITERIA: Patients with other risk factors known to cause gonadal insufficiency Patient suffering from acute or chronic systemic illness. Patient diagnosed to be having internal malignancy.

METHODOLOGY Anthropometric data, smoking, Duration of DM, alcohol consumption, medications & history suggestive of micro and macro-vascular complications. Symptoms of hypogonadism (ADAM Questionnaire). BMI ( kg∕m2){< 18.4 – underweight,18.5-22.9- normal, 23-24.9- overweight >25 –obese}. Waist circumference : (cut off upper limit 90cm (males) . Hip circumference: measurement taken at the level of greater trochanters Waist-to-hip Ratio : will be measured as a ratio WC/ HC Assessment of Microvascular complications

BIOCHEMICAL INVESTIGATIONS & BIOCHEMICAL DATA INTERPRETION FBG, lipid profile, LFT, KFT, serum electrolytes, HbA1c Urine sample: urine-R/M, UACR. Serum testosterone:electrochemiluminescence immunoassay “ECLIA” Normal values: Age group 20-49 years(249-836ng/dl) Age group> 50 years (193-740ng/dl) by using calibrator COBAS 411 by Roche. In this study, Low serum testosterone was defined as 20-49 years - <249 ng/dl, >50 years - <193ng/dl

LH and FSH Level-by “ECLIA”(LH: 1.7-8.6 IU/L, FSH: 1.5-12.4 IU/L) FBG: by Glucose oxidase- peroxidase (upper limit taken as 126mg/dl) . BLOOD UREA: by UREASE method (upper limit 50mg/dl). SERUM CREATININE: by JAFFES ALKALINE PICRATE method (upper limit 1.4mg/dl in males,) TOTAL CHOLESTEROL (TC): by CHOLESTEROL OXIDASE(upper limit 200mg/dl. TRIGLYCERIDE (TG): Done by GPO–PAP–ESPAS method (upper limit 150mg/dl). HDL- PEG-PAP method (lower limit 40mg/dl (males). LDL-(cut off upper limit is 100 mg/dl) HbA1c- LATEX AGGLUTINATION INHIBITION method (cut off upper limit 6.5%) Urinary micro-albuminuria : by IMMUNOTURBIDIOMETRY. Urinary albumin :creatinine ratio more than 30 mg/g labelled as micro-albuminuria.

STATISTICAL ANALYSIS Quantitative variables were compared using Unpaired t-test between the two groups. Qualitative variables were correlated using Chi-Square test. Univariate and multivariate logistic regression was used to assess the association of low testostrone with various parameters. Pearson correlation coefficient was used to find out association of various parameters with testosterone. A p value of <0.05 was considered statistically significant Data was entered in MS EXCEL spreadsheet and analysed using Statistical Package for Social Sciences (SPSS) version 21.0.

OBSERVATIONS & RESULTS Age and various other anthropometric measurements [Mean± SD] Variables DM Healthy P value Age(years) 50.54±5.93 48.96±9.17 0.199 BMI(kg/m2) 24.69±4.39 22.60±3.30 0.001 WAIST(cm) 87.10±9.45 82.31±6.71 <0.0001 Testosterone(ng/dl) 341.11±177.63 435.97±149.69 <0.001

Testosterone level association with Various Anthropometric measurements in DM (mean ± SD) Parameter Group Mean (±SD) p-value Duration of diabetes 5-10 375.85 ±180.28 0.007 >10 260.20 ±144.37 Age 35-45 387.50 ±141.59 0.416   46-55 330.90 ±192.43 56-65 316.72 ±174.82 BMI Normal 376.10 ±147.28 0.010 Overweight 330.66 ±198.66 Obese 311.26 ±189.23 Waist <=90 341.40 ±169.4 0.987 >90 340.76 ±192.71 ADAM Absent 393.66 ±165.53 <0.0005 Present 183.62 ±105.93

Testosterone level association with Microvascular complications in DM (mean ± SD) Parameter Group Mean (±SD) p-value Retinopathy (N=35) Absent 400.27 ±165.75 0.001 Present 265.14 ±164.79 Neuropathy (N=45) 432.64 ±167.76 <0.0005 269.99 ±151.81 Nephropathy (27) 352.14 ±159.48 0.483 319.57 ±210.32

Testosterone levels in different groups classified according to biochemical parameters in DM(mean ± SD) Parameter Group Mean (±SD) p-value FBG <=110(N=6) 284.40 ± 153.1 0.419 >110(N=74) 345.75 ± 179.56 HbA1C <=7(34) 284.40 ±162.86 0.008 >7(46) 345.75 ±176.54 Dyslipidemia Absent 371.42 ±188.43 0.03 Present 287.92 ±144.85

Relationship between serum testosterone level and symptoms of androgen deficiency in diabetic group by using ADAM questionnaire. ADAM questionnaire Normal SERUM TESTOSTERONE Low SERUM TESTOSTERONE Total p-value   No 51(85.00%) 9(15.00%) 60(100%) <0.0005 Yes 5(25.00%) 15(75.00%) 20(100%) 56(70.00%) 24(30.00%) 80(100%)

CONCLUSION Serum Testosterone Levels (ng/dl) are significantly lower in DM >5 years duration compared to healthy population Study shows an significant association of low serum testosterone level with following factors in DM: HIGH BMI LONGER DURATION OF DM M ICROVASCULAR COMPLICATION(RETINOPATHY,NEUROPATHY) INCREASING HbA1C ADAM QUESTIONNAIRE DYSLIPIDAEMIA

Strengths: one of the few studies that have assessed the association of testosterone with control of and development of complications of diabetes. possible necessity to measure the serum testosterone levels in type 2 diabetics. Limitations It was a carried out in a tertiary care centre, cross sectional study Determination of SHBG and free serum testosterone levels were not carried out

Thank you